4BIO Capital Fund II | 2015 VC Fund

4BIO Capital

cb Email

Status

ACTIVE

Global HQ

London, England, United Kingdom

Countries of investment

USA
United Kingdom
France
Japan

Investment stages

Seed

Industries

Pharma
Biotechnology

About
4BIO Capital is an international venture capital firm specializing in the advanced therapies sector. They invest in and support early stage companies developing treatments in areas of high unmet medical need, focusing on cell and gene therapy, RNA based treatments, and targeted delivery platforms.

Min check size: $1M
Max check size: $5M
Fund size: Unlock
NPS: Unlock

Investment Thesis

4BIO Capital aims to address high unmet medical and social needs by investing in advanced therapies and life sciences. The firm targets companies that are pioneering breakthroughs in biotech and related fields, with a focus on highgrowth potential and high returns.

Lead investor: Unlock
Co Invest: Unlock
Number of exits: Unlock
Preferred contact method: Unlock

Manager's Experience

Top-tier fund specializing in early-stage biotechnology investments, with a geographic focus on North America and Europe. The manager has completed over 30 deals, achieving multiple notable IPOs and acquisitions. Renowned for its operator-led investment style, emphasizing deep industry expertise and support for portfolio companies. Demonstrates a strategic, contrarian approach to identifying high-potential opportunities.